1. Home
  2. BHVN vs CNK Comparison

BHVN vs CNK Comparison

Compare BHVN & CNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • CNK
  • Stock Information
  • Founded
  • BHVN 2013
  • CNK 1984
  • Country
  • BHVN United States
  • CNK United States
  • Employees
  • BHVN N/A
  • CNK N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • CNK Movies/Entertainment
  • Sector
  • BHVN Health Care
  • CNK Consumer Discretionary
  • Exchange
  • BHVN Nasdaq
  • CNK Nasdaq
  • Market Cap
  • BHVN 3.6B
  • CNK 3.8B
  • IPO Year
  • BHVN 2017
  • CNK 2007
  • Fundamental
  • Price
  • BHVN $39.17
  • CNK $29.81
  • Analyst Decision
  • BHVN Strong Buy
  • CNK Buy
  • Analyst Count
  • BHVN 13
  • CNK 12
  • Target Price
  • BHVN $63.00
  • CNK $30.92
  • AVG Volume (30 Days)
  • BHVN 1.2M
  • CNK 1.8M
  • Earning Date
  • BHVN 02-27-2025
  • CNK 02-14-2025
  • Dividend Yield
  • BHVN N/A
  • CNK N/A
  • EPS Growth
  • BHVN N/A
  • CNK 99.28
  • EPS
  • BHVN N/A
  • CNK 1.64
  • Revenue
  • BHVN N/A
  • CNK $2,874,100,000.00
  • Revenue This Year
  • BHVN N/A
  • CNK N/A
  • Revenue Next Year
  • BHVN $197.13
  • CNK $11.03
  • P/E Ratio
  • BHVN N/A
  • CNK $17.53
  • Revenue Growth
  • BHVN N/A
  • CNK N/A
  • 52 Week Low
  • BHVN $26.80
  • CNK $13.45
  • 52 Week High
  • BHVN $62.21
  • CNK $36.28
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 51.03
  • CNK 39.93
  • Support Level
  • BHVN $35.01
  • CNK $28.39
  • Resistance Level
  • BHVN $39.36
  • CNK $30.67
  • Average True Range (ATR)
  • BHVN 2.07
  • CNK 0.77
  • MACD
  • BHVN 0.50
  • CNK -0.09
  • Stochastic Oscillator
  • BHVN 77.83
  • CNK 38.37

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About CNK Cinemark Holdings Inc Cinemark Holdings Inc.

Cinemark Holdings Inc is geographically diverse operators in the motion picture exhibition industry in the United States. The company operates in around 518 theatres and 5,847 screens in the United States and Latin America. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rental and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals and electronic video games located in some of the theatres. Majority of Cinemark's theaters are located in midsize cities or suburbs of large cities.

Share on Social Networks: